FCDGC: MAN2A2 Enzyme Variant Causes New Type of Congenital Disorder of Glycosylation
5 dic 2022 ·
1 min. 56 sec.
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022,...
mostra di più
New research from the Frontiers in Congenital Disorders of Glycosylation Consortium (FCDGC). This summary is based on a paper published in the Journal of Medical Genetics on November 10, 2022, titled "Homozygous truncating variant in MAN2A2 causes a novel congenital disorder of glycosylation with neurological involvement."
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
mostra meno
Read the paper here: https://jmg.bmj.com/content/early/2022/11/10/jmg-2022-108821
Learn more about FCDGC: https://www.rarediseasesnetwork.org/fcdgc
Informazioni
| Autore | RDCRN |
| Sito | - |
| Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
